Summary
This chapter critically examines the evidence for the existence of two classes of cell membrane adenosine receptors in peripheral tissues. This concept has been based on two types of observation. 1) Adenosine receptor activation can have either stimulatory or inhibitory effects on adenylate cyclase activity in isolated cells. 2) A series of adenosine analogues exhibit two different and distinct orders of potency on a range of both biochemical and pharmacological preparations. These observations provide suggestive, but not conclusive, evidence for the existence of two receptor types. The different effects of adenosine on adenylate cyclase activity may represent differentiation of stimulus-effect coupling, rather than two structurally dissimilar receptors. The two distinct orders of potency of adenosine analogues may not be solely due to their different affinities for two types of receptor. They may also be a reflection of the different efficacies of these analogues. Consequently, the development of selective antagonists is necessary in order to establish the existence of two types of adenosine receptor.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Ariens, E.J., Beld, A.J., Rodrigues de Miranda, J.F., and Simonis, A.M. (1979) In The Receptors, a comprehensive treatise. (ed. R.D. O’Brien). Plenum Press, New York.
Brown, C.M. and Collis, M.G. (1981). Eur. J. Pharmacol., 76, 275–277.
Brown, C.M. and Collis, M.G. (1982). Br. J. Pharmacol., 76, 381–387.
Brown, C.M. and Collis, M.G. (1983). Eur. J. Pharmacol, 93, 277–282.
Bruns, R.F. (1980). Can. J. Physiol. Pharmacol., 58, 673–691.
Bruns, R.F., Daly, J.W., and Snyder, S.H. (1980). Proc. Natl. Acad. Sci. U.S.A., 77, 5547–5551.
Burnstock, G. (1978) In Cell Membrane Receptors for Drugs and Hormones. (eds. R.W. Straub and L. Bolis). Raven Press, New York.
Burnstock, G. and Brown, C.M. (1981). In Purinergic Receptors. (ed. G. Burnstock). Chapman and Hall, London.
Collis, M.G. (1983). Br. J. Pharmacol., 78, 207–212.
Collis, M.G. and Brown, C.M. (1983). Eur J. Pharmacol. 96, 61–69.
Collis, M.G. and Saville, V.I. (1984). Br. J. Pharmacol., In Press.
Daly, J.W. (1982). J. Med. Chem., 25, 197–207.
Drew, G.M. and Whiting, S.B. (1979) Br. J. Pharmacol., 67, 207–215.
Edvinsson, L. and Fredholm, B.B. (1983). Br. J. Pharmacol., 80, 631–637.
Fredholm, B.B. (1982). Med. Biol., 60, 289–293.
Fredholm, B.B. and Persson, C.G.A. (1982). Eur. J. Pharmacol., 81, 673–676.
Furchgott, R.F. (1972). In Handbook of Experimental Pharmacology. (eds. H. Blaschko and E. Muscholl). Springer-Verlag, Berlin.
Gustafsson, L. (1981). Acta. Physiol. Scand., 111, 263–268.
Gustafsson, L. (1982). Acta. Physiol. Scand., T14, 38A.
Hedquist, P. and Fredholm, B.B. (1976). Naunyn-Schmiedebergs Arch. Pharmacol., 293, 217–223.
Holck, M.I. and Marks, B.H. (1978). J. Pharmacol. Exp. Ther., 205, 104–117.
Hughes, P.R. and Stone, T.W. (1983). Br. J. Pharmacol., 80, 149–153.
Kenakin, T.P. (1983). T.I.P.S. 4, 291–295.
Londos, C. and Wolff, J. (1977). Proc. Natl. Acad. Sci. U.S.A., 74, 5482–5486.
Londos, C., Cooper, D.M., and Wolff, J. (1980). Proc. Natl. Acad.
Sci. U.S.A., 77, 2551–2554.
Olsson, R.A., Davis, C.J., Khouri, E.M. and Patterson. R.E.
(1976). Circ. Res., 39, 93–98.
Paton, D.M. (1981). J. Auton. Pharmacol., 1, 287–290.
Plagemann, P.G., and Wohiheuter, R.M. (1984). Biochem Pharmacol., 33, 1783–1788.
Sakai, K.K., Hymson, D.L. and Shapiro, R. (1979). Life Sci., 24, 1299–1308.
Schrader, J., Nees, S. and Gerlack, E. (1977). Pflugers Arch, 369, 251–257.
Schwabe, U. and Trost, T. (1980). Naunyn-Schmiedebergs Arch. Pharmacol., 313, 179–187.
Schwabe, U. 1983). In Regulatory Function of Adenosine. (eds.
R.M. Berne, T.W. Rall, and R. Rubio). Martinus Nijhoff, Boston.
Trost, T. and Stock, K. (1977). Naunyn-Schmiedebergs Arch.
Pharmacol., 299, 33–40.
Ueland, P.M. (7982). Pharmacol. Rev., 34, 223–253.
Van Calker, D., Muller, M. and Hamprecht, B. (1979). J.
Neurochem., 33, 999–1005.
Verhaeghe, R.H., Vanhoutte, P.M. and Shepherd, J.T. (1977). Circ. Res., 40, 208–215.
Williams, M. and Risley, E.A. (1980). Proc. Natl. Acad. Sci. U.S.A., 77, 6892–6896.
Wu, P.H., Phillis, J.W., Balls, K. and Rinaldi, B. (1980). Can. J. Physiol. Pharmacol., 58, 576–579.
Zimmerman, T.P., Schmitges, C.J., Wolberg, G., Deeprose, R.D.,
Duncan, G.S. Cuatrecasas, P. and Elion, G.B. (1980). Proc. Natl. Acad. Sci. U.S.A., 10, 5639–5643.
Editor information
Editors and Affiliations
Copyright information
© 1985 The Contributors
About this chapter
Cite this chapter
Collis, M.G. (1985). Are there two Types of Adenosine Receptors in Peripheral Tissues?. In: Stone, T.W. (eds) Purines. Satellite Symposia of the IUPHAR 9th International Congress of Pharmacology. Palgrave Macmillan, London. https://doi.org/10.1007/978-1-349-07564-5_8
Download citation
DOI: https://doi.org/10.1007/978-1-349-07564-5_8
Publisher Name: Palgrave Macmillan, London
Print ISBN: 978-1-349-07566-9
Online ISBN: 978-1-349-07564-5
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)